Department of Emergency Medicine, Karolinska University Hospital, Sweden; Department of Clinical Science, Intervention and Technology, (CLINTEC), Karolinska Institutet, Stockholm, Sweden.
Faculty of Medicine and Health, School of Health and Medical Sciences, Department of Surgery, Örebro University, Örebro, Sweden.
Clin Nutr. 2021 Mar;40(3):1348-1354. doi: 10.1016/j.clnu.2020.08.023. Epub 2020 Aug 27.
Observational studies have shown an association between hyperglycaemia and increased complications in orthopaedic patients. The aim of the study was to investigate if impaired preoperative glycaemic control, reflected by elevated HbA1c, was associated with adverse postoperative events in hip fracture patients.
160 patients (116 women and 44 men; age 80 ± 10 and BMI 24 ± 4; mean ± SD) with hip fractures were included in a prospective observational cohort study. The patients were divided into two groups, normal glycaemic control (NGC) and impaired glycaemic control (IGC) HbA1c ≥ 42 mmol/mol. The patients were also characterized according to BMI and nutritional status using MNA-SF (Minimal Nutritional Assessment Short Form). Complications within 30 days of surgery were classified according to Clavien-Dindo and 1-year mortality was compared between the groups.
Out of 160 patients, 18 had diabetes and 4 more had likely occult diabetes (HbA1c ≥ 48). Impaired glycaemic control (IGC) was seen in 29 patients (18.1%) and normal glycaemic control (NGC) in 131 (81.9%). In patients with NGC and IGC, no postoperative complications (Clavien-Dindo Grade 0) were seen in 64/131 vs. 14/29 (48.9 vs. 48.3%), Grade 1-3a in 54/131 vs. 14/29 (41.2 vs. 48.3%) and Grade 3b-5 in 13/131 vs. 1/29 (9.9 vs. 3.4%) respectively, p = NS. There were no differences in 30-day complications (p = 0.55) or 1-year mortality (p = 0.35) between the groups.
Elevated HbA1c at admission is not associated with increased complications or mortality after hip fracture surgery.
观察性研究表明,骨科患者的高血糖与并发症增加有关。本研究旨在探讨术前血糖控制受损(表现为 HbA1c 升高)是否与髋部骨折患者的不良术后事件相关。
纳入 160 例髋部骨折患者(116 名女性和 44 名男性;年龄 80 ± 10 岁,BMI 24 ± 4;平均值 ± 标准差)进行前瞻性观察队列研究。将患者分为两组,正常血糖控制组(NGC)和血糖控制受损组(IGC)HbA1c≥42mmol/mol。还根据 BMI 和 MNA-SF(简易营养评估量表)评估的营养状况对患者进行了特征描述。根据 Clavien-Dindo 对术后 30 天内的并发症进行分类,并比较两组患者的 1 年死亡率。
160 例患者中,18 例患有糖尿病,另有 4 例可能患有隐匿性糖尿病(HbA1c≥48mmol/mol)。29 例(18.1%)患者血糖控制受损(IGC),131 例(81.9%)患者血糖控制正常(NGC)。在 NGC 和 IGC 患者中,NGC 组 64/131(48.9%)例无术后并发症(Clavien-Dindo 分级 0),IGC 组 14/29(48.3%)例;NGC 组 54/131(41.2%)例为 1-3a 级,IGC 组 14/29(48.3%)例为 1-3a 级;NGC 组 13/131(9.9%)例为 3b-5 级,IGC 组 1/29(3.4%)例为 3b-5 级,两组间差异无统计学意义(p=NS)。两组患者 30 天内并发症(p=0.55)或 1 年死亡率(p=0.35)无差异。
入院时 HbA1c 升高与髋部骨折手术后并发症或死亡率增加无关。